Three-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B-Reference-Cited by-同舟云学术

Three-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B

Published:2011-01 Issue:1 Volume:140 Page:132-143
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Heathcote E. Jenny,Marcellin Patrick,Buti Maria,Gane Edward,De Man Robert A.,Krastev Zahary,Germanidis George,Lee Samuel S.,Flisiak Robert,Kaita Kelly,Manns Michael,Kotzev Iskren,Tchernev Konstantin,Buggisch Peter,Weilert Frank,Kurdas Oya Ovunc,Shiffman Mitchell L.,Trinh Huy,Gurel Selim,Snow–Lampart Andrea,Borroto–Esoda Katyna,Mondou Elsa,Anderson Jane,Sorbel Jeff,Rousseau Franck

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference31 articles.

1. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures;Lavanchy;J Viral Hepat,2004

2. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level;Chen;JAMA,2006

3. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors;Fattovich;J Hepatol,2008

4. The relationship between HBV-DNA levels and cirrhosis-related complications in Chinese with chronic hepatitis B;Yuan;J Viral Hepatol,2005

5. Serum hepatitis B virus DNA as a predictor of the development of cirrhosis and hepatocellular carcinoma;Chen;Curr Hepat Rep,2007

Cited by 405 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolution and diversity of the hepatitis B virus genome: Clinical implications;Virology;2024-10

2. Synthesis of Chiral Acyclic Pyrimidine Nucleoside Analogues from DHAP-Dependent Aldolases;Biomolecules;2024-06-25

3. Renal dysfunction during treatment of chronic hepatitis B with tenofovir disoproxyl fumarate and associated risk factors;European Journal of Gastroenterology & Hepatology;2024-02-23

4. Islatravir: evaluation of clinical development for HIV and HBV;Expert Opinion on Investigational Drugs;2024-01-26

5. Kronik Hepatit B Hastalarının İrdelenmesi ve Tedaviyi Kesme Kriterlerinin Değerlendirilmesi;Bozok Tıp Dergisi;2023-10-06